Compare · MDLN vs TNDM
MDLN vs TNDM
Side-by-side comparison of Medline Inc. (MDLN) and Tandem Diabetes Care Inc. (TNDM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and TNDM operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $44.40B, about 35.1x TNDM ($1.27B).
- Over the past year, MDLN is down 17.1% and TNDM is down 8.7% - TNDM leads by 8.3 points.
- TNDM has been more active in the news (30 items in the past 4 weeks vs 20 for MDLN).
- Both have 25 recent analyst ratings on file.
- Company
- Medline Inc.
- Tandem Diabetes Care Inc.
- Price
- $33.80+0.58%
- $18.47-4.35%
- Market cap
- $44.40B
- $1.27B
- 1M return
- -19.55%
- +0.00%
- 1Y return
- -17.07%
- -8.72%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2013
- News (4w)
- 20
- 30
- Recent ratings
- 25
- 25
Tandem Diabetes Care Inc.
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. Its products in development include t:sport insulin delivery system; and connected (mobile) health offerings. Tandem Diabetes Care, Inc. has a development and commercialization agreement with Dexcom, Inc. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)
- Director Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)
- Large owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Large owner Bcp 8 Holdings Mozart Manager L.L.C. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Medline's Prime Vendor model expands outside the United States
- Medline Inc. announces closing of upsized secondary offering of Class A common stock
- Medline announces participation in upcoming investor conferences
- MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Large owner Bx Mozart Ml-1 Holdco L.P. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)
Latest TNDM
- Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy
- EVP, Chief Strategy Officer Gasser Elizabeth Anne gifted 7,160 shares and received a gift of 7,160 shares, closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by PRESIDENT & CEO Sheridan John F
- SEC Form 4 filed by EVP, Chief Strategy Officer Gasser Elizabeth Anne
- SEC Form 4 filed by EVP & CHIEF FINANCIAL OFFICER Vosseller Leigh
- SEC Form 4 filed by EVP & Chief Operating Officer Kyrillos Jean-Claude
- SEC Form 4 filed by EVP & Chief Legal Officer Hansen Shannon Marie
- SEC Form 4 filed by EVP & Chief Admin. Officer Morrison Susan
- SEC Form 4 filed by EVP & Chief Technology Officer Carpenter Rick
- Tandem Diabetes Care upgraded by Wells Fargo with a new price target